메뉴 건너뛰기
Arthritis and Rheumatism
Volumn 64, Issue 10, 2012, Pages 3486-
Antiinflammatory strategies, not just B cell depletion, are required for optimal therapy for severe proliferative lupus nephritis: Comment on the article by Rovin et al
Author keywords

[No Author keywords available]
Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; RITUXIMAB;
EID: 84869007040     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34617     Document Type: Letter
Times cited : (1)
References (6)
  • 1
    • 84866184129 scopus 로고    scopus 로고
    • Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The Lupus Nephritis Assessment with Rituximab study
    • for the LUNAR Investigator Group
    • Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez- Guerrero J, et al, for the LUNAR Investigator Group. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment With Rituximab study. Arthritis Rheum 2012; 64: 1215-26.
    • (2012) Arthritis Rheum , vol.64 , pp. 1215-1226
    • Rovin, B.H.1    Furie, R.2    Latinis, K.3    Looney, R.J.4    Fervenza, F.C.5    Sanchez- Guerrero, J.6
  • 2
    • 84858393494 scopus 로고    scopus 로고
    • The landscape after LUNAR: Rituximab's crater-filled path [editorial]
    • Lightstone L. The landscape after LUNAR: rituximab's crater-filled path [editorial]. Arthritis Rheum 2012; 64: 962-5.
    • (2012) Arthritis Rheum , vol.64 , pp. 962-965
    • Lightstone, L.1
  • 4
    • 0035188299 scopus 로고    scopus 로고
    • Predictive power of the second renal biopsy in lupus nephritis: Significance of macrophages
    • DOI 10.1046/j.1523-1755.2001.00492.x
    • Hill GS, Delahousse M, Nochy D, Remy P, Mignon F, Mery JP, et al. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int 2001; 59: 304-16. (Pubitemid 32063019)
    • (2001) Kidney International , vol.59 , Issue.1 , pp. 304-316
    • Hill, G.S.1    Delahousse, M.2    Nochy, D.3    Remy, P.4    Mignon, F.5    Mery, J.-P.6    Bariety, J.7
  • 5
    • 73349117550 scopus 로고    scopus 로고
    • Adverse events and efficacy of TNF-blockade with infliximab in patients with systemic lupus erythematosus: Longterm follow-up of 13 patients
    • Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, et al. Adverse events and efficacy of TNF-blockade with infliximab in patients with systemic lupus erythematosus: longterm follow-up of 13 patients. Rheumatology (Oxford) 2009;48: 1451-4.
    • (2009) Rheumatology (Oxford) , vol.48 , pp. 1451-1454
    • Aringer, M.1    Houssiau, F.2    Gordon, C.3    Graninger, W.B.4    Voll, R.E.5    Rath, E.6
  • 6
    • 84863112185 scopus 로고    scopus 로고
    • Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis
    • Liu ZC, Zhou QL. Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis. Inflamm Res 2012; 61: 277-84.
    • (2012) Inflamm Res , vol.61 , pp. 277-284
    • Liu, Z.C.1    Zhou, Q.L.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.